Publications 2024

Johannessen A, Reikvam DH, Aleman S, Berhe N, Weis N, Desalegn H, Stenstad T, Heggelund L, Samuelsen E, Karlsen LN, Lindahl K, Pettersen FO, Iversen J, Kleppa E, Bollerup S, Winckelmann AA, Brugger-Synnes P, Simonsen HE, Svendsen J, Kran AB, Holmberg M, Olsen IC, Rueegg CS, Dalgard O (2024)
Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B
Aliment Pharmacol Ther, 60 (4), 434-445
DOI 10.1111/apt.18147, PubMed 38970293

Publications 2022

Campbell SM, Pettersen FO, Brekke H, Hanevik K, Robertson LJ (2022)
Transition to PCR diagnosis of cryptosporidiosis and giardiasis in the Norwegian healthcare system: could the increase in reported cases be due to higher sensitivity or a change in the testing algorithm?
Eur J Clin Microbiol Infect Dis, 41 (5), 835-839
DOI 10.1007/s10096-022-04426-3, PubMed 35243573

Mørch K, Pettersen FO (2022)
[Monkeypox in Norway]
Tidsskr Nor Laegeforen, 142 (10)
DOI 10.4045/tidsskr.22.0412, PubMed 35763853

Yaqub S, Jensenius M, Heieren OE, Drolsum A, Pettersen FO, Labori KJ (2022)
Echinococcosis in a non-endemic country - 20-years' surgical experience from a Norwegian tertiary referral Centre
Scand J Gastroenterol, 57 (8), 953-957
DOI 10.1080/00365521.2022.2046846, PubMed 35246008

Publications 2021

Fosheim IK, Lappen KR, Heldal K, Mariathasan AB, Lundesgaard KK, Benterud BP, Pettersen FO, Labori KJ, Yaqub S (2021)
[A young woman who did not awake after extensive surgery]
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0184, PubMed 34726048

Fosheim IK, Lappen KR, Heldal K, Mariathasan AB, Lundesgaard KK, Pettersen FO, Labori KJ, Yaqub S, Benterud BP (2021)
A young woman who did not wake up after extensive surgery
Tidsskr. Nor. Laegeforen., 141 (15), 1456-1461

Kristiansen T, Pettersen FO, Lier T, Hinderaker SG, Greve G, Mørch K (2021)
Schistosomiasis in Norwegian students after travel to Africa
Tidsskr Nor Laegeforen, 141 (3)
DOI 10.4045/tidsskr.20.0268, PubMed 33624965

Publications 2019

Schwartz T, Jensenius M, Blomberg B, Fladeby C, Mæland A, Pettersen FO (2019)
Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients
Trop Dis Travel Med Vaccines, 5, 16
DOI 10.1186/s40794-019-0092-x, PubMed 31463070

Wæhre T, Pettersen FO (2019)
[Poorer treatment options due to HIV drug tenders]
Tidsskr Nor Laegeforen, 139 (2)
DOI 10.4045/tidsskr.19.0016, PubMed 30698395

Publications 2018

Nordheim E, Olafsson Storrø M, Natvik AK, Birkeland Kro G, Midtvedt K, Varberg Reisaeter A, Hagness M, Fevang B, Pettersen FO (2018)
Donor-derived strongyloidiasis after organ transplantation in Norway
Transpl Infect Dis, 21 (1), e13008
DOI 10.1111/tid.13008, PubMed 30295406

Publications 2015

Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D (2015)
High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
J Acquir Immune Defic Syndr, 69 (4), 395-402
DOI 10.1097/QAI.0000000000000617, PubMed 26115437

Publications 2014

Lind A, Brekke K, Pettersen FO, Mollnes TE, Trøseid M, Kvale D (2014)
A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
PLoS One, 9 (1), e85604
DOI 10.1371/journal.pone.0085604, PubMed 24416431

Publications 2013

Ushakova A, Pettersen FO, Mæland A, Lindqvist BH, Kvale D (2013)
Bayesian estimation of HIV-1 dynamics in vivo
Math Med Biol, 32 (1), 38-55
DOI 10.1093/imammb/dqt018, PubMed 24078026

Publications 2011

Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
DOI 10.1128/JVI.00073-11, PubMed 21490090

Publications 2010

Pettersen FO, Taskén K, Kvale D (2010)
Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection
Clin Exp Immunol, 161 (2), 315-23
DOI 10.1111/j.1365-2249.2010.04179.x, PubMed 20491784

Publications 2009

Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM (2009)
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population
Eur J Immunol, 39 (5), 1280-7
DOI 10.1002/eji.200839002, PubMed 19384871

Publications 2008

Holm M, Pettersen FO, Kvale D (2008)
PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples
Curr HIV Res, 6 (1), 49-58
DOI 10.2174/157016208783571955, PubMed 18288975

Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008)
Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
J Infect Dis, 198 (10), 1474-81
DOI 10.1086/592713, PubMed 18851688